US20050287228A1 - Method and composition for improving fertility health in female and male animals and humans - Google Patents

Method and composition for improving fertility health in female and male animals and humans Download PDF

Info

Publication number
US20050287228A1
US20050287228A1 US11/214,927 US21492705A US2005287228A1 US 20050287228 A1 US20050287228 A1 US 20050287228A1 US 21492705 A US21492705 A US 21492705A US 2005287228 A1 US2005287228 A1 US 2005287228A1
Authority
US
United States
Prior art keywords
supplement
arginine
fertility
green tea
castus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/214,927
Inventor
Aileen Trant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US11/214,927 priority Critical patent/US20050287228A1/en
Publication of US20050287228A1 publication Critical patent/US20050287228A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/85—Verbenaceae (Verbena family)

Definitions

  • This invention provides combinations of bioeffecting compounds for promoting fertility in men and women.
  • the combinations include nutritional components that benefit fertility health. All the components have been studied separately, to determine their individual efficacy.
  • the invention provides the first products to put these components together synergistically in women's and men's formulations.
  • the invention provides combinations of beneficial bioeffecting compounds for promoting fertility in women.
  • the invention provides a scientifically validated herbal/nutritional blend for women to improve infertility by helping to regulate the menstrual cycle and correct hormone imbalance (corpus luteum insufficiency) without increased chances of multiple births associated with drug therapy.
  • the combination of amino acids, herbs, vitamins and minerals improves overall health and helps with many of the deficiencies that decrease fertility.
  • Vitex agnus-castus chasteberry
  • the herb, Vitex agnus-castus enhances hormone balance by increasing progesterone release and, therefore, ovulation frequency.
  • the antioxidants, green tea, vitamin E, and selenium improve overall reproductive health.
  • L-arginine an amino acid, stimulates the reproductive organs by improving circulation.
  • Folic acid, vitamins B6 and B 12, iron, zinc and magnesium help promote womens' fertility.
  • the invention provides combinations of beneficial bioeffecting compounds for promoting fertility in men.
  • Sperms are highly susceptible to free radical or oxidative damage from environmental toxicants and natural aging.
  • Vitamins C and E, coenzyme Q10 and selenium are all potent antioxidants that help improve sperm counts and quality.
  • Ferulic acid an antioxidant found in Dong quai, also improves sperm quality.
  • Zinc and B vitamins (B6, B12 and folate) are critical nutrients in male reproductive systems for hormone metabolism, sperm formation and motilitv. The amino acid. L-camitine, promotes formation of healthy sperm.
  • the invention provides synergistic action of the combinations.
  • the two dietary supplements in male and female formulas are useful for men and women.
  • the distinct combinations are taken by both members of a couple in which the female age is between 21 and 46.
  • the distinct combinations are useful for couples who have tried for 6 months or more, up to three years, to become pregnant without success.
  • patients take 2-4 capsules per day of the distinct formulas for three months.
  • women it is useful to record their basal temperature daily using thermometers and charts and to have their blood drawn for progesterone analysis at day 18-22 of the first menstrual cycle prior to taking the supplement.
  • Preferred ranges of the combinations considered in percent by weight are: Components Minimum % Maximum % Women's formula Vitex (chasteberry) 2 10 L-arginine 40 60 Green tea 5 20 Vitamin E 5 20 Selenium .01 1 Vitamins B6, B12 .01 1 Folic acid .01 1 Iron .1 5 Magnesium 10 40 Zinc .1 5
  • Examples of useful formulation in percent by weight are: Women's formula Components Vitex (chasteberry) 5 L-arginine 50 Green tea 11 Vitamin E 11 Selenium .03 Vitamins B6, B12 .03 Folic acid .03 Iron 1 Magnesium 20 Zinc 1 100%

Abstract

In a new pharmaceutical combination, the herb, Vitex agnus-castus (chasteberry), enhances hormone balance by increasing progesterone release and, therefore, ovulation frequency. The antioxidants, green tea, vitamin E, and selenium, improve overall reproductive health. L-arginine, an amino acid, stimulates the reproductive organs by improving circulation. Folic acid, vitamins B6 and B12, iron, zinc and magnesium help promote womens' fertility. Sperms are highly susceptible to free radical or oxidative damage from environmental toxicants and natural aging. Vitamins C and E, coenzyme Q10 and selenium are all potent antioxidants that help improve sperm counts and quality. Ferulic acid, an antioxidant found in Dong quai, also improves sperm quality. Zinc and B vitamins (B6, B12 and folate) are critical nutrients in male reproductive systems for hormone metabolism, sperm formation and motility. The amino acid, L-carnitine, promotes formation of healthy sperm.

Description

    BACKGROUND OF THE INVENTION
  • Because of delayed child bearing, unhealthy diets and use of tobacco, caffeine, alcohol, drugs and environmental contaminants, difficulties in conceiving have been experienced.
  • Needs exist for pharmaceutical compounds that improve fertility in both women and men.
    • SUMMARY OF THE INVENTION
  • This invention provides combinations of bioeffecting compounds for promoting fertility in men and women. The combinations include nutritional components that benefit fertility health. All the components have been studied separately, to determine their individual efficacy. The invention provides the first products to put these components together synergistically in women's and men's formulations.
  • As many as 15% of couples in the U.S. have difficulty conceiving a child. In about one third of these cases, it is the man that is infertile; in another third, the female has fertility issues. The remaining is due to a combination of male and female fertility issues, or unknown causes. In many of these cases, causes of infertility are treatable. Nutritional and lifestyle changes should be the first step to increasing chances for conception. Smoking and caffeine, drug and alcohol consumption. environmental toxicants, and stress are related to infertility in men and women. Reproductive organs are highly susceptible to free radical or oxidative damage from environmental toxicants and natural aging. A balanced, nutritional diet, and nutritional supplements with high antioxidant content can help reverse some of that damage. In women, hormone balance is critical to monthly ovulation and development of the corpus luteum (an ovarian follicle that release progesterone after release of the egg to prepare the uterus for implantation).
  • These and further and other objects and features of the invention are apparent in the disclosure, which includes the above ongoing written specification with the claims.
    • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • The invention provides combinations of beneficial bioeffecting compounds for promoting fertility in women. The invention provides a scientifically validated herbal/nutritional blend for women to improve infertility by helping to regulate the menstrual cycle and correct hormone imbalance (corpus luteum insufficiency) without increased chances of multiple births associated with drug therapy. The combination of amino acids, herbs, vitamins and minerals improves overall health and helps with many of the deficiencies that decrease fertility.
  • The herb, Vitex agnus-castus (chasteberry), enhances hormone balance by increasing progesterone release and, therefore, ovulation frequency. The antioxidants, green tea, vitamin E, and selenium, improve overall reproductive health. L-arginine, an amino acid, stimulates the reproductive organs by improving circulation. Folic acid, vitamins B6 and B 12, iron, zinc and magnesium help promote womens' fertility.
  • The invention provides combinations of beneficial bioeffecting compounds for promoting fertility in men. Sperms are highly susceptible to free radical or oxidative damage from environmental toxicants and natural aging. Vitamins C and E, coenzyme Q10 and selenium are all potent antioxidants that help improve sperm counts and quality. Ferulic acid, an antioxidant found in Dong quai, also improves sperm quality. Zinc and B vitamins (B6, B12 and folate) are critical nutrients in male reproductive systems for hormone metabolism, sperm formation and motilitv. The amino acid. L-camitine, promotes formation of healthy sperm.
  • The invention provides synergistic action of the combinations.
  • The two dietary supplements in male and female formulas are useful for men and women. Preferably, the distinct combinations are taken by both members of a couple in which the female age is between 21 and 46. The distinct combinations are useful for couples who have tried for 6 months or more, up to three years, to become pregnant without success. Preferably, patients take 2-4 capsules per day of the distinct formulas for three months. In women it is useful to record their basal temperature daily using thermometers and charts and to have their blood drawn for progesterone analysis at day 18-22 of the first menstrual cycle prior to taking the supplement. For men, it is useful to submit a sperm sample at the same time for analysis of count and motility. Prior to submitting sperm samples, 2-4 days abstinence is suggested for best results. No fevers over 101 degrees in the three months prior to taking the new combinations should be encountered. It is useful to repeat the analyses during the fourth menstrual cycle of the study. The first month is needed to develop baselines, followed by three months of taking the combinations product or placebo.
  • Preferred ranges of the combinations considered in percent by weight are:
    Components Minimum % Maximum %
    Women's formula
    Vitex (chasteberry) 2 10
    L-arginine 40 60
    Green tea 5 20
    Vitamin E 5 20
    Selenium .01 1
    Vitamins B6, B12 .01 1
    Folic acid .01 1
    Iron .1 5
    Magnesium 10 40
    Zinc .1 5
  • Men's Formula
    Components Minimum % Maximum %
    L-carnitine 40 70
    Ferulic acid in Dong Quai .1 10
    Vitamins C and E 10 30
    Coenzyme coQ10 .1 5
    Selenium .01 1
    Zinc .1 10
    B vitamins .001 1
  • Acceptable ranges of womens' and mens' formulations are:
    Women's Formula
    Components Minimum % Maximum %
    Vitex (chasteberry) 1 20
    L-arginine 20 70
    Green tea 0 30
    Vitamin E 0 30
    Selenium 0 2
    Vitamins B6, B12 0 2
    Folic acid 0 2
    Iron 0 7
    Magnesium 5 50
    Zinc .01 10
  • Men's Formula
    Components Minimum % Maximum %
    L-carnitine 20 80
    Ferulic acid in Dong Quai 0 20
    Vitamins C and E .01 40
    Coenzyme coQ10 .01 10
    Selenium 0 3
    Zinc .01 15
    B vitamins 0 5
  • Examples of useful formulation in percent by weight are:
    Women's formula
    Components
    Vitex (chasteberry) 5
    L-arginine 50
    Green tea 11
    Vitamin E 11
    Selenium .03
    Vitamins B6, B12 .03
    Folic acid .03
    Iron 1
    Magnesium 20
    Zinc 1
    100%
  • Men's Formula
    Components
    L-carnitine 60
    Ferulic acid in Done Quai 6
    Vitamins C and E 25
    Coenzyme coQ10 3
    Selenium 6
    Zinc 5
    B Vitamins 4
    100%
  • While the invention has been described with references to specific embodiments, modifications and variations of the invention may be constructed without departing from the scope of the invention, which is defined in the following ciaims.

Claims (46)

1-9. (canceled)
10. A supplement, comprising a herb, Vitex agnus-castus (chasteberry) for enhancing hormone balance, increasing progesterone release and ovulation frequency, antioxidants, green tea, vitamin E, and selenium for improving reproductive fertility, L-arginine, an amino acid for stimulating reproductive organs by improving circulation, folic acid, vitamins B6 and B12, iron, zinc and magnesium for promoting women's fertility.
11. A method of promoting fertility health in women comprising taking a dietary supplement of L-arginine, magnesium, green tea, vitamin E, Vitex agnus-castus, iron, zinc, selenium, vitamins B6 and B12 and folic acid.
12. The method of claim 11, wherein the dietary supplement further comprises the following components in percentages by weight: about 50% L-arginine, about 20% magnesium, about 5% green tea, about 11% vitamin E, about 5% Vitex, about 1% iron, about 1% zinc and less than about 1% of each selenium, vitamins B6 and B12 and folic acid.
13. The method of claim 11, wherein the components are present in the proportion in parts by weight of about 10 to 80% L-arginine, an amino acid, about 5 to 50% magnesium, about 5 to 50% antioxidants, including green tea, vitamin E or selenium, 2 to 20% Vitex agnus-castus (chasteberry), about 0.1 to 10% iron, about 0.1 to 10% zinc, about 0.001 to 1% folic acid, about 0.001 to 1% vitamins B6 and B12.
14. The method of claim 11, wherein the components are present in the proportion in parts by weight of about 40 to 80% L-arginine, an amino acid, about 20 to 50% antioxidants, including green tea, vitamin E or selenium, about 20 to 50% magnesium, about 4 to 20% Vitex agnus-castus (chasteberry), about 1 to 10% iron, about 1 to 10 % zinc, about 0.01 to 1% folic acid, and about 0.3 to 1% vitamins B6 and B12.
15. A method for promoting fertility health in women comprising taking a supplement having fertility promoting activity in females comprising in combination components in effective amounts of the following components present in proportions in parts by weights of about 10 to 80% L-arginine, an amino acid, about 5 to 50% magnesium, about 5 to 50% antioxidants, including green tea, vitamin E or selenium, 2 to 20% Vitex agnus-castus (chasteberry), about 0.1 to 10% iron, about 0.1 to 10% zinc, about 0.001 to 1% folic acid, about 0.001 to 1% vitamins B6 and B12.
16. A method for promoting fertility health in women comprising taking a supplement having fertility promoting activity in females comprising in combination components in effective amounts of the following components present in proportions in parts by weights of about 40 to 80% L-arginine, an amino acid, about 20 to 50% antioxidants, including green tea, vitamin E or selenium, about 20 to 50% magnesium, about 4 to 20% Vitex agnus-castus (chasteberry), about 1 to 10% iron, about 1 to 10 % zinc, about 0.01 to 1% folic acid, and about 0.3 to 1% vitamins B6 and B12.
17. A method for promoting fertility health in women comprising taking a supplement having fertility promoting activity in females comprising in combination components in effective amounts of the following components present in proportions in parts by weights of about 10 to 80% L-arginine, an amino acid, about 10 to 50% magnesium, about 5 to 50% antioxidants, including green tea, vitamin E or selenium, about 1 to 20% Vitex agnus-castus (chasteberry), about 0.1 to 10% iron.
18. A method of promoting a women's fertility by taking a new supplement, comprising a herb, Vitex agnus-castus (chasteberry) for enhancing hormone balance, increasing progesterone release and ovulation frequency, antioxidants, green tea, vitamin E, and selenium for improving overall reproductive health, L-arginine, an amino acid for stimulating reproductive organs by improving circulation, folic acid, vitamins B6 and B12, iron, zinc and magnesium for promoting women's' fertility.
19. A supplement for promoting women's fertility comprising an herb for enhancing hormone balance, increasing progesterone release and ovulation frequency and an amino acid for stimulating reproductive organs by improving circulation.
20. The supplement of claim 19, wherein the herb is Vitex agnus-castus.
21. The supplement of claim 20, wherein the amino acid is L-arginine.
22. The supplement of claim 21, further comprising one or more antioxidants for improving reproductive fertility.
23. The supplement of claim 22, wherein the antioxidants are selected from the group consisting of green tea, vitamin E, selenium, and combinations thereof.
24. The supplement of claim 22, further comprising folic acid.
25. The supplement of claim 24, further comprising vitamins B6 and B12.
26. The supplement of claim 25, further comprising iron, zinc and magnesium.
27. A method of promoting fertility health in women comprising taking a dietary supplement comprising an herb for enhancing hormone balance, increasing progesterone release and ovulation frequency and an amino acid for stimulating reproductive organs by improving circulation.
28. The method of claim 27, wherein the taking a dietary supplement comprises taking the supplement comprising L-arginine and Vitex agnus-castus.
29. The method of claim 27, wherein the taking a dietary supplement comprises taking the supplement comprising one or more antioxidants.
30. The method of claim 29, wherein the antioxidants are selected from the group consisting of green tea, vitamin E, selenium, and combinations thereof.
31. The method of claim 29, wherein the taking a dietary supplement comprises taking the supplement comprising iron, magnesium, zinc, and combinations thereof.
32. The method of claim 31, wherein the taking the supplement comprises taking the supplement comprising vitamins B6 and B12.
33. The method of claim 32, wherein the taking the supplement comprises taking the supplement comprising folic acid.
34. The method of claim 33, wherein the dietary supplement further comprises the following components in percentages by weight: about 50% L-arginine, about 20% magnesium, about 5% green tea, about 11% vitamin E, about 5% Vitex, about 1% iron, about 1% zinc and less than about 1% of each of selenium, vitamins B6 and B12 and folic acid.
35. The method of claim 33, wherein the components are present in the proportion in parts by weight of about 10 to 80% L-arginine, an amino acid, about 5 to 50% magnesium, about 5 to 50% antioxidants, including green tea, vitamin E or selenium, 2 to 20% Vitex agnus-castus (chasteberry), about 0.1 to 10% iron, about 0.1 to 10% zinc, about 0.001 to 1% folic acid, about 0.001 to 1% vitamins B6 and B12.
36. The method of claim 33, wherein the components are present in the proportion in parts by weight of about 40 to 80% L-arginine, an amino acid, about 20 to 50% antioxidants, including green tea, vitamin E or selenium, about 20 to 50% magnesium, about 4 to 20% Vitex agnus-castus (chasteberry), about 1 to 10% iron, about 1 to 10 % zinc, about 0.01 to 1% folic acid, and about 0.3 to 1% vitamins B6 and B12.
37. A method for promoting fertility health in women comprising taking a supplement having fertility promoting activity in females comprising in combination components in effective amounts present in proportions in parts by weights of about 10 to 80% L-arginine and about 2 to 20% Vitex agnus-castus.
38. The method of claim 37, further comprising in combination components in effective amounts present in proportions in parts by weights of about 5 to 50% magnesium, about 5 to 50% antioxidants including green tea, vitamin E or selenium, about 0.1 to 10% iron, about 0.1 to 10% zinc, about 0.001 to 1% folic acid, about 0.001 to 1% vitamins B6 and B12.
39. A method for promoting fertility health in women comprising taking a supplement having fertility promoting activity in females comprising in combination components in effective amounts present in proportions in parts by weights of about 40 to 80% L-arginine and about 4 to 20% Vitex agnus-castus.
40. The method of claim 39, further comprising in combination components in effective amounts present in proportions in parts by weights of about 20 to 50% antioxidants, including green tea, vitamin E or selenium, about 20 to 50% magnesium, about 1 to 10% iron, about 1 to 10 % zinc, about 0.01 to 1% folic acid, and about 0.3 to 1% vitamins B6 and B12.
41. A method for promoting fertility health in women comprising taking a supplement having fertility promoting activity in females comprising in combination components in effective amounts present in proportions in parts by weights of about 10 to 80% L-arginine and about 1 to 20% Vitex agnus-castus.
42. The method of claim 41, further comprising in combination components in effective amounts present in proportions in parts by weights of about 10 to 50% magnesium, about 5 to 50% antioxidants including green tea, vitamin E or selenium, about 0.1 to 10% iron.
43. A method of promoting a women's fertility by taking a new supplement, comprising an herb Vitex agnus-castus (chasteberry) for enhancing hormone balance, increasing progesterone release and ovulation frequency, an amino acid L-arginine for stimulating reproductive organs by improving circulation, and antioxidants for improving overall reproductive health.
44. The method of claim 43, wherein the antioxidants are selected from the group consisting of green tea, vitamin E, selenium, and combinations thereof.
45. The method of claim 44, further comprising folic acid, vitamins B6 and B12, iron, zinc and magnesium for promoting women's fertility.
46. A supplement for improving fertility health comprising effective amounts of components of Vitex agnus-castus (chasteberry), green tea, and L-arginine for improving reproductive fertility, treating female infertility, enhancing hormone balance, stimulating reproductive organs, increasing progesterone release, increasing ovulation rate, and increasing pregnancy rate.
47. The supplement of claim 46, wherein the components are present in parts by weight of about 74% L-arginine, about 18.5% green tea, and about 7.4% Vitex agnus-castus (chasteberry).
48. The supplement of claim 46, wherein the components are present in parts by weight of about 10 to 80% L-arginine, about 5 to 50% green tea, and about 2 to 20% Vitex agnus-castus (chasteberry).
49. The supplement of claim 46, wherein the components are present in parts by weight of about 40 to 80% L-arginine, about 20 to 50% green tea, and about 4 to 20% Vitex agnus-castus (chasteberry).
50. A method for improving and promoting fertility health in women comprising taking a supplement having fertility promoting activity in females comprising in combination components in parts by weights of about 10 to 80% L-arginine, about 5 to 50% green tea, and about 2 to 20% Vitex agnus-castus (chasteberry) for improving reproductive fertility, treating female infertility, enhancing hormone balance, stimulating reproductive organs, increasing progesterone release, increasing ovulation rate, and increasing pregnancy rate.
51. A method of improving and promoting fertility health in women comprising taking a dietary supplement of effective amounts of components of L-arginine, green tea, and Vitex agnus-castus (chasteberry) for improving reproductive fertility, treating female infertility, enhancing hormone balance, stimulating reproductive organs, increasing progesterone release, increasing ovulation rate, and increasing pregnancy rate.
52. The method of claim 51, wherein the dietary supplement comprises the components in percentages by weight of about 74% L-arginine, about 18.5% green tea, and about 7.4% Vitex agnus-castus (chasteberry).
53. The method of claim 51, wherein the components are present in the parts by weight of about 10 to 80% L-arginine, about 5 to 50% green tea, and about 2 to 20% Vitex agnus-castus (chasteberry).
54. The method of claim 51,, wherein the components are present in parts by weight of about 40 to 80% L-arginine, abbut 20 to 50% green tea, and about 4 to 20% Vitex agnus-castus (chasteberry).
US11/214,927 2000-12-22 2005-08-31 Method and composition for improving fertility health in female and male animals and humans Abandoned US20050287228A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/214,927 US20050287228A1 (en) 2000-12-22 2005-08-31 Method and composition for improving fertility health in female and male animals and humans

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/742,412 US6497885B2 (en) 2000-12-22 2000-12-22 Method and composition for improving fertility health in female and male animals and humans
US10/252,698 US7045151B2 (en) 2000-12-22 2002-09-24 Method and composition for improving fertility health in female and male animals and humans
US11/214,927 US20050287228A1 (en) 2000-12-22 2005-08-31 Method and composition for improving fertility health in female and male animals and humans

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/252,698 Division US7045151B2 (en) 2000-12-22 2002-09-24 Method and composition for improving fertility health in female and male animals and humans

Publications (1)

Publication Number Publication Date
US20050287228A1 true US20050287228A1 (en) 2005-12-29

Family

ID=24984736

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/742,412 Expired - Lifetime US6497885B2 (en) 2000-12-22 2000-12-22 Method and composition for improving fertility health in female and male animals and humans
US10/252,698 Expired - Lifetime US7045151B2 (en) 2000-12-22 2002-09-24 Method and composition for improving fertility health in female and male animals and humans
US11/214,927 Abandoned US20050287228A1 (en) 2000-12-22 2005-08-31 Method and composition for improving fertility health in female and male animals and humans

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US09/742,412 Expired - Lifetime US6497885B2 (en) 2000-12-22 2000-12-22 Method and composition for improving fertility health in female and male animals and humans
US10/252,698 Expired - Lifetime US7045151B2 (en) 2000-12-22 2002-09-24 Method and composition for improving fertility health in female and male animals and humans

Country Status (1)

Country Link
US (3) US6497885B2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080102141A1 (en) * 2006-10-30 2008-05-01 Maria Antoinette Brandes Use as a means to improve fertility of a phytotherapeutic composition and method for improving and/or promoting fertility health
AT503219B1 (en) * 2006-02-03 2008-07-15 Annerl Brigitte COMBINATION PREPARATION BASED ON ANTIOXIDANTS TO IMPROVE THE SEED QUALITY
US20100159036A1 (en) * 2006-10-30 2010-06-24 Maria Antoinette Brandes Use as a means to improve fertility of a phytotherapeutic composition and method for improving and/or promoting fertility health
US7901710B2 (en) 2005-08-04 2011-03-08 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US7998500B2 (en) 2005-08-04 2011-08-16 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US8202546B2 (en) 2005-08-04 2012-06-19 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8263137B2 (en) 2005-08-04 2012-09-11 Vertical Pharmaceuticals, Inc. Nutritional supplement for women

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6497885B2 (en) * 2000-12-22 2002-12-24 The Daily Wellness Company Method and composition for improving fertility health in female and male animals and humans
US20040043013A1 (en) 2000-12-28 2004-03-04 Mccleary Edward Larry Metabolic uncoupling therapy
US20060110478A1 (en) * 2004-11-22 2006-05-25 Mccleary Edward L Delivery system and method for supporting and promoting healthy sexual function and prevention and treatment of sexual dysfunction
US20030059489A1 (en) * 2001-09-24 2003-03-27 Canolio Inc. Genital lubricating compositions and uses thereof
WO2003037343A1 (en) * 2001-10-30 2003-05-08 Lonza Ag Composition comprising folic acid and carnitine useful to enhance male fertility
DE10304590A1 (en) * 2003-02-05 2005-01-27 Heinz Kiefer Use of a medicament comprising Agni casti fructus, Cimicifugae racemosae rhizoma and D-alpha-tocopherol for treating climacteric disorders involving impaired libido
US20040228931A1 (en) * 2003-05-12 2004-11-18 Pharmachem Laboratories, Inc. Novel composition for hormonal balance and uses thereof
DK1529445T3 (en) * 2003-11-04 2007-06-11 Korfitsen Jens Peter Corfitz Nutritional Composition
US7410657B2 (en) * 2004-09-30 2008-08-12 Ai Ja Lee Alternative remedy-based composition for enhancing fertility
WO2006053217A1 (en) * 2004-11-12 2006-05-18 Mccleary, Edward Larry Weight loss composition and method
WO2006057893A2 (en) * 2004-11-22 2006-06-01 Edward Larry Mccleary Composition, delivery system and method for promoting healthy sexual function
FR2884691B1 (en) * 2005-04-21 2007-07-20 Formquest Ltd FOOD SUPPLEMENT COMPRISING A COMBINATION OF ANTIOXIDANT AGENTS AND ENERGY AGENTS USEFUL AS AID FOR FERTILITY IN MAN AND IN WOMEN
EP1902710A4 (en) * 2005-07-04 2009-12-02 Univ Tokyo Medical & Dental Pharmaceutical composition and beverage composition comprising l-arginine
WO2007003007A1 (en) * 2005-07-05 2007-01-11 Adelaide Fertility Centre Pty Ltd Methods and compositions for improving pregnancy outcome
WO2007059605A1 (en) * 2005-11-04 2007-05-31 Bio Syntech Canada Inc. Composition and method for efficient delivery of nucleic acids to cells using chitosan
FR2893848B1 (en) * 2005-11-28 2011-11-11 Physcience PHYTOHORMONAL COMPOSITION AND ITS USE AS A HORMONAL SUBSTITUTE
ITBO20060544A1 (en) * 2006-07-21 2008-01-22 Angelo Chieregati PREPARATION FOR CARE OF INFERTILITY
EP3087858B1 (en) 2008-06-13 2021-04-28 NIKE Innovate C.V. Footwear having sensor system
US9002680B2 (en) * 2008-06-13 2015-04-07 Nike, Inc. Foot gestures for computer input and interface control
US9549585B2 (en) 2008-06-13 2017-01-24 Nike, Inc. Footwear having sensor system
US10070680B2 (en) 2008-06-13 2018-09-11 Nike, Inc. Footwear having sensor system
ES2333842B1 (en) * 2009-11-30 2011-02-10 Laboratorios Q Pharma S.L. PHARMACEUTICAL COMPOSITION INTENDED TO IMPROVE THE QUALITY OF THE Sperm.
JP5868848B2 (en) * 2010-05-21 2016-02-24 株式会社カネカ Pig feed and its feeding method
FR2964834B1 (en) * 2010-09-21 2012-09-28 Marc Cohen ANTI-OXIDIZING COMPOSITION FOR PREVENTING INFERTILITY IN MAN
EP2638491B1 (en) 2010-11-10 2022-10-05 NIKE Innovate C.V. Systems and methods for time-based athletic activity measurement and display
US9381420B2 (en) 2011-02-17 2016-07-05 Nike, Inc. Workout user experience
KR101853239B1 (en) 2011-02-17 2018-04-27 나이키 이노베이트 씨.브이. Location mapping
CA2827687C (en) 2011-02-17 2016-12-20 Nike International Ltd. Footwear having sensor system
KR101896204B1 (en) 2011-02-17 2018-09-07 나이키 이노베이트 씨.브이. Footwear having sensor system
US20130213146A1 (en) 2012-02-22 2013-08-22 Nike, Inc. Footwear Having Sensor System
US11071344B2 (en) 2012-02-22 2021-07-27 Nike, Inc. Motorized shoe with gesture control
US20130213147A1 (en) 2012-02-22 2013-08-22 Nike, Inc. Footwear Having Sensor System
US11684111B2 (en) 2012-02-22 2023-06-27 Nike, Inc. Motorized shoe with gesture control
DE102012217387A1 (en) * 2012-09-26 2014-04-17 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Therapeutic use of hydrogen molecules
US9775874B1 (en) 2012-09-28 2017-10-03 The Daily Wellness Company Method for treating symptoms of hormone imbalance
US10926133B2 (en) 2013-02-01 2021-02-23 Nike, Inc. System and method for analyzing athletic activity
US9743861B2 (en) 2013-02-01 2017-08-29 Nike, Inc. System and method for analyzing athletic activity
US11006690B2 (en) 2013-02-01 2021-05-18 Nike, Inc. System and method for analyzing athletic activity
US9279734B2 (en) 2013-03-15 2016-03-08 Nike, Inc. System and method for analyzing athletic activity
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US400276A (en) * 1889-03-26 Grip-pulley wheel
US4321262A (en) * 1976-12-29 1982-03-23 Burnett Harvey L Medicament for arthritic conditions
US6242012B1 (en) * 1999-10-19 2001-06-05 Thomas Newmark Herbal composition for promoting hormonal balance in women and methods of using same
US6338862B1 (en) * 2001-03-26 2002-01-15 Sarfaraz K Niazi Composition and method of use in treating sexual dysfunction using cGMP-specific phosphodiesterase type 5 inhibitors
US6368640B1 (en) * 1998-04-03 2002-04-09 The Daily Wellness Company Method and composition for improving sexual fitness
US6497885B2 (en) * 2000-12-22 2002-12-24 The Daily Wellness Company Method and composition for improving fertility health in female and male animals and humans

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2878124A (en) * 1956-03-10 1959-03-17 Bayer Ag Food additives
US3015567A (en) * 1959-03-20 1962-01-02 Du Pont Process for enriching the l-lysine content of food and the resulting product
US3360374A (en) * 1965-07-27 1967-12-26 Courtland Lab Process for making a dietary food product
JPS5133633B2 (en) 1973-08-31 1976-09-21
US3970750A (en) 1974-10-08 1976-07-20 Sandoz, Inc. Effervescent potassium chloride composition
US4168307A (en) * 1974-11-08 1979-09-18 Mitsubishi Chemical Industries Limited N2 -Naphthalenesulfonyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof
ZA773318B (en) 1976-06-18 1978-04-26 I Kleinberg Means and method for improving natural defenses against caries
US4340592A (en) 1980-03-14 1982-07-20 Adibi Siamak A Nutrient compositions and method of administering the same
JPS575692A (en) 1980-06-13 1982-01-12 Ajinomoto Co Inc Production of l-arginine through fermentation process
IT1133026B (en) 1980-06-30 1986-07-09 Manetti & Roberts Italo Brit D, L-PYROGLUTAMATE I L-ARGININE-BASED DRESSING WITH TOUCH ACTIVITY AT NEURO-ENDOCRINE LEVEL
JPS5793913A (en) 1980-12-03 1982-06-11 Ajinomoto Co Inc Enhancing agent for spermous vital power
JPS5855418A (en) 1981-09-25 1983-04-01 Akira Endo Remedy for hyperlipemia
CH655005A5 (en) 1983-02-16 1986-03-27 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITION WITH METABOLIC AND ENERGY ACTION USABLE IN CARDIAC AND VASCULAR THERAPY.
US5334617A (en) * 1984-03-19 1994-08-02 The Rockefeller University Amino acids useful as inhibitors of the advanced glycosylation of proteins
US5034377A (en) 1984-11-19 1991-07-23 Montefiore Hospital Association Of Western Pennsylvania Aqueous nutrient compositions comprising oligopeptides
GB8603171D0 (en) * 1986-02-08 1986-03-12 Howard A N Dietary product
US5248688A (en) * 1986-09-10 1993-09-28 Dudrick Medical Research Fund I, Ltd. Method and substrate composition for treating atherosclerosis
US5032608A (en) 1986-09-10 1991-07-16 Dudrick Stanley J Method and substrate composition for treating atherosclerosis
US4920098A (en) 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
US5041429A (en) * 1988-06-01 1991-08-20 Sanwa Kagaku Kenkyusho Co., Ltd. Cell activators, circulatory ameliorators and edible compositions
US5036052A (en) * 1988-06-22 1991-07-30 Morishita Pharmaceutical Co., Ltd. Amino acid nutrient compositions
US4954526A (en) 1989-02-28 1990-09-04 The United States Of America As Represented By The Department Of Health And Human Services Stabilized nitric oxide - primary amine complexes useful as cardiovascular agents
CA1335361C (en) * 1989-05-24 1995-04-25 Andrei Z. Budzynski Thrombus-targeted complexes of plasminogen activator and fibrin fragments
US5380945A (en) * 1989-06-21 1995-01-10 Abbott Laboratories Guanidino compounds as regulators of nitric oxide synthase
US4957938A (en) * 1989-06-21 1990-09-18 Abbott Laboratories Nutritional formulation for the treatment of renal disease
US5464644A (en) 1989-09-27 1995-11-07 Kellogg Company Ready-to-eat-cereal containing psyllium and use thereof for lowering cholesterol levels
US5157022A (en) 1989-11-22 1992-10-20 Adrian Barbul Method for reducing blood cholesterol using arginine
JP2960947B2 (en) 1989-12-25 1999-10-12 日清製粉株式会社 Lipolytic enzyme inhibitors
US5576351A (en) 1989-12-29 1996-11-19 Mcgaw, Inc. Use of arginine as an immunostimulator
EP0441119A3 (en) 1990-01-09 1992-10-14 Richard D. Levere The use of l-arginine in the treatment of hypertension and other vascular disorders
EP0528950B1 (en) 1990-05-16 1996-09-11 Zbigniew Walaszek Formula and method for the prevention and treatment of hypercholesterolemia and cellular hyperproliferative disorders
US5278189A (en) 1990-06-04 1994-01-11 Rath Matthias W Prevention and treatment of occlusive cardiovascular disease with ascorbate and substances that inhibit the binding of lipoprotein (A)
US5650418A (en) 1990-06-04 1997-07-22 Therapy 2000 Therapeutic lysine salt composition and method of use
US5106836A (en) 1991-02-22 1992-04-21 Clintec Nutrition Co. Enteral diet
US5171217A (en) 1991-02-28 1992-12-15 Indiana University Foundation Method for delivery of smooth muscle cell inhibitors
US5385937A (en) 1991-04-10 1995-01-31 Brigham & Women's Hospital Nitrosation of homocysteine as a method for treating homocysteinemia
FR2675692A1 (en) 1991-04-24 1992-10-30 Oreal ANTI-OXIDANT SYSTEM CONTAINING PYRROLIDONE CARBOXYLATE LYSINE AND / OR ARGININE PYRROLIDONE CARBOXYLATE EITHER BEING ASSOCIATED WITH A PHENOLIC DERIVATIVE AND ITS USE IN COSMETICS.
CA2066951A1 (en) 1991-04-26 1992-10-27 Kou Moriyama Edible composition
US5977073A (en) * 1991-06-06 1999-11-02 Life Sciences' Technologies, Inc. Nutrient composition for treatment of immune disorders
JP2702322B2 (en) * 1991-08-08 1998-01-21 フジックス株式会社 Active amino acid calcium, beverage containing the same, and method for producing the same
US5374651A (en) * 1991-09-27 1994-12-20 Board Of Regents, The University Of Texas System Methods and compositions for the treatment of hypotension with arginine free essential and essential amino acids and arginine derivatives
JPH05163139A (en) 1991-12-12 1993-06-29 Ajinomoto Co Inc Antiarteriosclerotic agent
US5262435A (en) * 1992-02-10 1993-11-16 Merck & Co., Inc. Cholesterol lowering compounds
US5221668A (en) * 1992-02-26 1993-06-22 Abbott Laboratories Nutritional product for trauma and surgery patients
WO1993018156A1 (en) 1992-03-05 1993-09-16 The General Hospital Corporation Endothelial nitric oxide synthase
US5780039A (en) 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
GB9214247D0 (en) 1992-07-04 1992-08-19 Stephan Peter M Composition for use as a food or food supplement
US5385940A (en) * 1992-11-05 1995-01-31 The General Hospital Corporation Treatment of stroke with nitric-oxide releasing compounds
US5326569A (en) * 1992-12-23 1994-07-05 Abbott Laboratories Medical foods for the nutritional support of child/adult metabolic diseases
US5439938A (en) 1993-04-07 1995-08-08 The Johns Hopkins University Treatments for male sexual dysfunction
JPH06321786A (en) 1993-05-12 1994-11-22 Sekisui Chem Co Ltd Agent for inhibiting absorption of bile acid in enteric canal
US5945452A (en) 1993-06-11 1999-08-31 The Board Of Trustees Of The Leland Stanford Junior University Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
US5428070A (en) 1993-06-11 1995-06-27 The Board Of Trustees Of The Leland Stanford Junior University Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity
US5852058A (en) 1993-06-11 1998-12-22 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
US5891459A (en) 1993-06-11 1999-04-06 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
US5861168A (en) 1993-06-11 1999-01-19 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
ZA9410015B (en) 1993-09-15 1995-11-08 William Henry Davis A pharmaceutical composition
JP3398449B2 (en) 1993-12-10 2003-04-21 常春 黒木 Cattle sexing method
US5500266A (en) 1994-03-10 1996-03-19 Eastman Kodak Company Spin-coating compensation for an optical storage medium with a substrate groove profile gradient
US5626883A (en) 1994-04-15 1997-05-06 Metagenics, Inc. Ascorbic acid compositions providing enhanced human immune system activity
US5576287A (en) 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
US5631031A (en) 1994-06-13 1997-05-20 Meade; Thomas L. Water-insoluble amino acid salt
US5543430A (en) 1994-10-05 1996-08-06 Kaesemeyer; W. H. Method and formulation of stimulating nitric oxide synthesis
US5594032A (en) 1994-11-10 1997-01-14 Gonzalez-Cadavid; Nestor F. Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA
US5523087A (en) 1995-02-15 1996-06-04 Bio-Virus Research Incorporated Pharmaceutical compositions for the treatment of diabetic male sexual dysfunction
US5545414A (en) * 1995-03-22 1996-08-13 Abbott Laboratories Cholesterol lowering food product
US5897864A (en) 1996-05-23 1999-04-27 Cohen; Alan J. Method for treating sexual dysfunction disorders with compositions containing ginkgo biloba
US5730987A (en) 1996-06-10 1998-03-24 Omar; Lotfy Ismail Medication for impotence containing lyophilized roe and a powdered extract of Ginkgo biloba
US5883086A (en) * 1997-05-02 1999-03-16 Craft; John C. DHEA-containing nutritional supplement
JP3926888B2 (en) * 1997-05-27 2007-06-06 株式会社カネカ Cholesterol lowering agent
US6117872A (en) 1998-06-23 2000-09-12 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of exercise performance by augmenting endogenous nitric oxide production or activity
US6007824A (en) 1998-07-09 1999-12-28 Duckett; Melvin J. Natural composition and method for the treatment of sexual dysfunction

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US400276A (en) * 1889-03-26 Grip-pulley wheel
US4321262A (en) * 1976-12-29 1982-03-23 Burnett Harvey L Medicament for arthritic conditions
US6368640B1 (en) * 1998-04-03 2002-04-09 The Daily Wellness Company Method and composition for improving sexual fitness
US6544563B2 (en) * 1998-04-03 2003-04-08 The Daily Wellness Company Method and composition for improving sexual fitness
US6242012B1 (en) * 1999-10-19 2001-06-05 Thomas Newmark Herbal composition for promoting hormonal balance in women and methods of using same
US6497885B2 (en) * 2000-12-22 2002-12-24 The Daily Wellness Company Method and composition for improving fertility health in female and male animals and humans
US6338862B1 (en) * 2001-03-26 2002-01-15 Sarfaraz K Niazi Composition and method of use in treating sexual dysfunction using cGMP-specific phosphodiesterase type 5 inhibitors

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7901710B2 (en) 2005-08-04 2011-03-08 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US7998500B2 (en) 2005-08-04 2011-08-16 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US8197854B2 (en) 2005-08-04 2012-06-12 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8202546B2 (en) 2005-08-04 2012-06-19 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8263667B2 (en) 2005-08-04 2012-09-11 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8263137B2 (en) 2005-08-04 2012-09-11 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
AT503219B1 (en) * 2006-02-03 2008-07-15 Annerl Brigitte COMBINATION PREPARATION BASED ON ANTIOXIDANTS TO IMPROVE THE SEED QUALITY
US20080102141A1 (en) * 2006-10-30 2008-05-01 Maria Antoinette Brandes Use as a means to improve fertility of a phytotherapeutic composition and method for improving and/or promoting fertility health
US20100159036A1 (en) * 2006-10-30 2010-06-24 Maria Antoinette Brandes Use as a means to improve fertility of a phytotherapeutic composition and method for improving and/or promoting fertility health

Also Published As

Publication number Publication date
US20030026851A1 (en) 2003-02-06
US7045151B2 (en) 2006-05-16
US20020122834A1 (en) 2002-09-05
US6497885B2 (en) 2002-12-24

Similar Documents

Publication Publication Date Title
US6497885B2 (en) Method and composition for improving fertility health in female and male animals and humans
CA2481603A1 (en) Method and composition for improving fertility health in female and male animals and humans
Sheehan et al. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis
Dennehy The use of herbs and dietary supplements in gynecology: an evidence-based review
KR102376425B1 (en) Composition useful for promoting female fertility
Chiofalo et al. Influence of dietary supplementation of Rosmarinus officinalis L. on performances of dairy ewes organically managed
Jayaganthan et al. Effects of Tinospora cordifolia supplementation on semen quality and hormonal profile in rams
US20070104801A1 (en) Fertility and anti-aging supplement for the fertility health of females and males
WO2020262325A1 (en) Anti-aging agent for females
Liu et al. Effects of chlorogenic acids-enriched extract from Eucommia ulmoides leaves on growth performance, stress response, antioxidant status and meat quality of lambs subjected or not to transport stress
KR20070093437A (en) Formulations and treatments for well-being
Adaay et al. Effect of aqueous and ethanolic extracts of Tribulus terrestris, Phoenix dactylifera and Nasturtium officinale mixture on some reproductive parameters in male mice
Khan et al. Supplementation of vitamins, probiotics and proteins on oxidative stress, enzymes and hormones in post-moult male broiler breeders
El-Zaher et al. Ovarian activity and antioxidant indices during estrous cycle of Barki ewes under effect of thyme, celery and salinomycin as feed additives
Sarfaraz et al. Effect of different doses of lyophilized beetroot on fertility and reproductive hormones.
KR101596728B1 (en) Composition comprising zinc/red ginseng, octacosanol and vitamin for preventing and ameliorating andropause symptoms
US6989164B2 (en) Method and composition for improving male fertility health
Sadogh et al. Herbal foodstuffs in Avicenna’s recommended diet to improve sperm quality and increase male fertility; an evidence-based approach
Mohssin et al. Effect of royal jelly on male infertility
US9775874B1 (en) Method for treating symptoms of hormone imbalance
US6673366B1 (en) Breast enhancement system
Yaseen et al. Flavonoid enriched supplementation abrogates prenatal stress and enhances goat kids performance reared in a sub-tropical environment
AU2021104673A4 (en) Poly herbal green tea supplement for improving implantation & fertility
Refaie et al. Impact of dietary supplementation of milk thistle (Silybum marianum) seed extract on doe rabbits performance
Dillasamola et al. The effect of giving red-fleshed watermelon juice (citrullus lanatus (thunb.)) on pregnant white mice (mus musculus) exposed by Monosodium Glutamate (MSG) orally on the number and morphology of fetus

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION